Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Barker-Haliski

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Journal of Alzheimer'S Disease : JAD|January 9, 2025
Seizing the opportunity to therapeutically address neuronal hyperexcitability in Alzheimer's diseaseMelissa Barker-Haliski
Epilepsy Currents|March 9, 2026
Microglia on Leave: PLX5622 Reveals Immune Neuronal Crosstalk in Epilepsy and Behavioral ComorbiditiesMelissa Barker-Haliski
Epilepsy Currents|July 3, 2026
Clinical Failure Validates a Fifth Predictive Preclinical Antiseizure Medicine Discovery ModelMelissa Barker-Haliski
Expert Opinion on Drug Discovery|June 29, 2019
How do we choose the appropriate animal model for antiseizure therapy development?Melissa Barker-Haliski
Epilepsy Currents|December 23, 2024
Gut Instincts: Unusual Suspects in Seizure WorseningInga Erickson, Melissa Barker-Haliski
Epilepsy Currents|February 19, 2026
Benchmarks to Breakthroughs: How the 2007 Epilepsy Research Benchmarks Reframed Scientific and Clinical Trajectories of 21st-Century Epilepsy CareQian Wu, Melissa Barker-Haliski
Cold Spring Harbor Perspectives in Medicine|June 24, 2015
Glutamatergic Mechanisms Associated with Seizures and EpilepsyMelissa Barker-Haliski, H Steve White
Epilepsy Currents|May 5, 2025
Fyn-ding Novel Therapeutic Targets for Temporal Lobe Epilepsy-Unlikely Partners at the Hippocampal SynapseLarissa Robinson-Cooper, Melissa Barker-Haliski
Neuropharmacology|August 31, 2019
Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screeningMelissa Barker-Haliski, H Steve White
Experimental Neurology|December 6, 2022
Cannabidiol reveals a disruptive strategy for 21st century epilepsy drug discoveryAaron Del Pozo, Melissa Barker-Haliski
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Journal of Alzheimer'S Disease : JAD|January 9, 2025
Seizing the opportunity to therapeutically address neuronal hyperexcitability in Alzheimer's diseaseMelissa Barker-Haliski
Epilepsy Currents|March 9, 2026
Microglia on Leave: PLX5622 Reveals Immune Neuronal Crosstalk in Epilepsy and Behavioral ComorbiditiesMelissa Barker-Haliski
Epilepsy Currents|July 3, 2026
Clinical Failure Validates a Fifth Predictive Preclinical Antiseizure Medicine Discovery ModelMelissa Barker-Haliski
Expert Opinion on Drug Discovery|June 29, 2019
How do we choose the appropriate animal model for antiseizure therapy development?Melissa Barker-Haliski
Epilepsy Currents|December 23, 2024
Gut Instincts: Unusual Suspects in Seizure WorseningInga Erickson, Melissa Barker-Haliski
Epilepsy Currents|February 19, 2026
Benchmarks to Breakthroughs: How the 2007 Epilepsy Research Benchmarks Reframed Scientific and Clinical Trajectories of 21st-Century Epilepsy CareQian Wu, Melissa Barker-Haliski
Cold Spring Harbor Perspectives in Medicine|June 24, 2015
Glutamatergic Mechanisms Associated with Seizures and EpilepsyMelissa Barker-Haliski, H Steve White
Epilepsy Currents|May 5, 2025
Fyn-ding Novel Therapeutic Targets for Temporal Lobe Epilepsy-Unlikely Partners at the Hippocampal SynapseLarissa Robinson-Cooper, Melissa Barker-Haliski
Neuropharmacology|August 31, 2019
Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screeningMelissa Barker-Haliski, H Steve White
Experimental Neurology|December 6, 2022
Cannabidiol reveals a disruptive strategy for 21st century epilepsy drug discoveryAaron Del Pozo, Melissa Barker-Haliski
Pageof 6